Publications by authors named "M Hisatomi"
The identities of unidentified persons are often confirmed by matching dental treatment information. Although treatment restorations consisting of artificial materials can be confirmed visually and/or by X-ray photography, they should be quantitatively analyzed. This study demonstrates that effective atomic number (Z) images can be created using photon-counting computed tomography (PC-CT) and used to identify artificial materials employed in dentistry.
View Article and Find Full Text PDFArticle Synopsis
- The study explores the prevalence of steatotic liver disease (SLD) using the new multisociety consensus nomenclature, identifying its different subtypes such as MASLD and MetALD among 6,530 health check-up participants in Japan.
- Results indicate a 39.5% overall prevalence of SLD, with most cases classified as MASLD, and a small portion showing significant fibrosis as determined by liver stiffness measurement.
- Although the FIB-4 index is convenient for assessing liver fibrosis, its diagnostic performance as a primary screening tool is limited, particularly in the general population, suggesting the need for more effective screening methods.
Purpose: The current supraomohyoid neck dissection (SOHND) is performed above the omohyoid muscle to dissect levels I, II, and III in the levels of cervical lymph nodes. However, the anatomical boundary between levels III and IV is the inferior border of the cricoid cartilage. We investigated the anatomical relationship between the omohyoid muscle and cricoid cartilage using contrast-enhanced CT (CE-CT) images to assess the validity of the current SOHND.
View Article and Find Full Text PDFCisplatin is a platinum-based compound that is widely used for treating inoperable oral squamous cell carcinoma (OSCC) in Japan; however, resistance to cisplatin presents a challenge and innovative approaches are required. We aimed to investigate the therapeutic potential of targeting the chemokine receptor CXCR4, which is involved in angiogenesis and tumor progression, using the CXCR4 inhibitor AMD3100, in combination with cisplatin. AMD3100 induced necrosis and bleeding in OSCC xenografts by inhibiting angiogenesis.
View Article and Find Full Text PDF